A Message from bioAffinity Technologies

PUBLISHED ON October 4, 2015

SAN ANTONIO, TX (October 4, 2015) Early detection of cancer prolongs life. Each of us at bioAffinity Technologies has seen this firsthand. Our brothers, sisters, parents, friends and patients, and many of us personally, have benefited from early cancer detection.

read more

Clinical Study for Non-Invasive Lung Cancer Test Reports Promising Results

PUBLISHED ON September 23, 2015

SAN ANTONIO, TX (September 23, 2015) bioAffinity Technologies, a privately held cancer diagnostics company, today announced that results from a 128-patient proof-of-concept clinical study for its non-invasive and quantitative assay for early-stage lung cancer were published in the Journal of Thoracic Oncology.

read more

bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.

 

www.thehealthcell.org/sitepage/state-of-the-industry/